Today: 1 May 2026
Citi to cut 1,000 jobs as BlackRock trims 250 in latest Wall Street layoffs
14 January 2026
1 min read

Citi to cut 1,000 jobs as BlackRock trims 250 in latest Wall Street layoffs

New York, Jan 13, 2026, 21:40 EST

  • Citigroup is set to slash roughly 1,000 positions this week as CEO Jane Fraser drives forward a multi-year restructuring plan
  • BlackRock plans to eliminate around 250 jobs, approximately 1% of its workforce, citing a routine efficiency review
  • Citi shares slipped roughly 1.2% in late trading, while BlackRock saw little movement

Citigroup (C) plans to slash roughly 1,000 positions this week, according to a source who spoke to Reuters. CEO Jane Fraser continues to push for cost reductions and improved returns at the bank.

Timing is key. As big financial firms approach earnings, investors remain fixated on expense lines, not just top-line revenue, following years of ramped-up spending on controls and systems.

BlackRock (BLK), the world’s largest asset manager, announced plans to cut roughly 250 jobs, about 1% of its global staff, calling it a routine move to boost efficiency. CEO and co-founder Larry Fink has been steering the company toward private markets—investments outside public exchanges.

Bloomberg reported that BlackRock is trimming jobs across its investment and sales departments, indicating the layoffs go beyond just back-office positions.

Citi didn’t reveal how many jobs it plans to cut but said its headcount will continue to decline into 2026. A spokesperson told Human Resources Online the bank is tweaking staffing and locations, pointing to “efficiencies we have gained through technology.” They added, “We are grateful for the contributions these colleagues have made to Citi.” Human Resources Online

Citi reported around 229,000 full-time employees at the close of 2024, per its latest annual filing. The bank plans to slash 20,000 jobs by the end of 2026, a target set two years ago. Fraser’s late-2023 strategy focuses on boosting earnings and tightening up data governance — essentially how the bank handles and verifies its information — along with risk management. This revamp has triggered departures in wealth management and tech divisions, while Gonzalo Luchetti has stepped in as CFO, replacing Mark Mason. Citi runs roughly 650 U.S. branches, mostly clustered in six big metro areas, and will release its Q4 earnings on Wednesday.

In late New York trading, Citi shares slipped roughly 1.2%, with BlackRock holding steady.

But cost cuts can backfire. Severance expenses, employee turnover, and operational disruptions can spike fast—especially with regulators scrutinizing controls and data management closely.

At this stage, both companies describe the layoffs as routine adjustments rather than strategic pullbacks. That said, the scale and duration of these cuts will draw closer scrutiny once earnings reports begin to roll in.

Stock Market Today

  • Avalyn Pharma upsizes IPO to $300 million, Alector halts study with GSK
    May 1, 2026, 12:10 AM EDT. Avalyn Pharma, a Boston-based biotech, is raising $300 million by selling 16.5 million shares at $18 each in an upsized initial public offering (IPO). The capital raise aims to fund its drug development programs. Separately, Alector, in partnership with GlaxoSmithKline (GSK), has terminated another clinical study, though further details remain limited. These moves reflect ongoing volatility and strategic shifts within the biotech sector as firms adjust pipelines and capital strategies amid challenging market conditions.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 01.05.2026

1 May 2026
LIVEMarkets rolling coverageStarted: May 1, 2026, 12:00 AM EDTUpdated: May 1, 2026, 12:10 AM EDT Avalyn Pharma upsizes IPO to $300 million, Alector halts study with GSK May 1, 2026, 12:10 AM EDT. Avalyn Pharma, a Boston-based biotech, is raising $300 million by selling 16.5 million shares at $18 each in an upsized initial public offering (IPO). The capital raise aims to fund its drug development programs. Separately, Alector, in partnership with GlaxoSmithKline (GSK), has terminated another clinical study, though further details remain limited. These moves reflect ongoing volatility and strategic shifts within the biotech sector as firms adjust pipelines
Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Snowflake stock drops 5% after Barclays downgrade, with March earnings now in focus
Previous Story

Snowflake stock drops 5% after Barclays downgrade, with March earnings now in focus

BHP stock ends higher as China’s iron ore surge meets merger talk — what’s next for ASX:BHP
Next Story

BHP stock ends higher as China’s iron ore surge meets merger talk — what’s next for ASX:BHP

Go toTop